Regístrese
Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia
Journal Information
Issue
Vol. 43. Issue 2.
Pages 119-236 (March - April 2015)
In this issue
In this issue of A&I
Luis Garcia-Marcos
Allergol Immunopathol (Madr). 2015;43:119
Original articles
Real life study of three years omalizumab in patients with difficult-to-control asthma
J. Jesús López Tiro, E. Angélica Contreras Contreras, M. Elena Ramírez del Pozo, J. Gómez Vera, D. Larenas Linnemann
Allergol Immunopathol (Madr). 2015;43:120-6
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs
Paola Lucia Minciullo, Alessandro Allegra, Anna D’Angelo, Caterina Musolino, Sebastiano Gangemi
Allergol Immunopathol (Madr). 2015;43:127-30
Level of serum neutrophil gelatinase-associated lipocalin in childhood asthma
A.Z. Akelma, M.K. Kanburoglu, M.N. Cizmeci, E. Mete, F. Catal, N. Tufan
Allergol Immunopathol (Madr). 2015;43:142-6
Indicators for childhood asthma in Spain, using the Rand method
J. Ruiz-Canela-Cáceres, N. Aquino-Llinares, J.M. Sánchez-Diaz, M.L. García-Gestoso, M.E. de Jaime-Revuelta, M. Praena-Crespo
Allergol Immunopathol (Madr). 2015;43:147-56
Prevalence of allergic diseases and/or allergic sensitisation in children and adolescents with type 1 diabetes mellitus
H. Villa-Nova, A.M. Spinola-Castro, F.E. Garcia, D. Solé
Allergol Immunopathol (Madr). 2015;43:157-61
Activation of coagulation in chronic urticaria in relation to disease severity and activity
M.N. Farres, M. Refaat, N.A. Melek, E.E. Ahmed, M.G. Shamseldine, N.A. Arafa
Allergol Immunopathol (Madr). 2015;43:162-7
Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria
P.M. Silva, A.C. Costa, A. Mendes, M.P. Barbosa
Allergol Immunopathol (Madr). 2015;43:168-73
Methacholine challenge test by wheezing and oxygen saturation in preschool children with asthma
S. Caussade, J.A. Castro-Rodriguez, S. Contreras, R. Bugueño, R. Ramirez, O. Padilla, H. Einisman, N. Holmgren
Allergol Immunopathol (Madr). 2015;43:174-9
Quality of sleep in allergic children and their parents
E. Ridolo, C. Caffarelli, E. Olivieri, M. Montagni, C. Incorvaia, I. Baiardini, G.W. Canonica
Allergol Immunopathol (Madr). 2015;43:180-4
Review
Epidemiology of food allergy in Latin America
J. Sánchez, A. Sánchez
Allergol Immunopathol (Madr). 2015;43:185-95
Legumes steam allergy in childhood: Update of the reported cases
G. Vitaliti, P. Pavone, G. Spataro, L. Giunta, F. Guglielmo, R. Falsaperla
Allergol Immunopathol (Madr). 2015;43:196-202
Perioperative anaphylactic reactions: Review and procedure protocol in paediatrics
A.V. Michavila Gomez, Mª.T. Belver Gonzalez, N. Cortés Alvarez, Mª.T. Giner Muñoz, V. Hernando Sastre, J.A. Porto Arceo, B. Vila Induráin
Allergol Immunopathol (Madr). 2015;43:203-14
Research letters
Are skin prick tests really safe? A case of anaphylaxis caused by skin prick testing with inhalant allergens
A. Babayigit Hocaoglu, F. Cipe, C. Aydogmus
Allergol Immunopathol (Madr). 2015;43:215-6
Successful oral tolerance induction to cow's milk in a child with allergy to extensively hydrolysed formula
N. Santos, A. Gaspar, L.M. Borrego, M. Morais-Almeida
Allergol Immunopathol (Madr). 2015;43:216-8
Coconut anaphylaxis: Case report and review
A. Michavila Gomez, M. Amat Bou, M.V. Gonzalez Cortés, L. Segura Navas, M.A. Moreno Palanques, B. Bartolomé
Allergol Immunopathol (Madr). 2015;43:219-20
Audit of the use of intravenous immunoglobulin for antibody deficiencies in a Clinical Immunology Unit
L. Arriaran, J. Gil, E. Fernandez-Cruz, J. Carbone
Allergol Immunopathol (Madr). 2015;43:220-2
Effects of cedar pollen extract on the immune system in vitro
W. Fukushima, A. Honda, R. Murayama, Y. Matsuda, K. Tsuji, T. Hayashi, T. Sawahara, S. Ozawa, Y. Okamoto, H. Takano
Allergol Immunopathol (Madr). 2015;43:222-4
Type 1 diabetes mellitus and asthma: A follow-up study
G. d’Annunzio, M.A. Tosca, A. Pistorio, M. Silvestri, G. Romanisio, R. Lorini, G.A. Rossi, G. Ciprandi
Allergol Immunopathol (Madr). 2015;43:225-7
Use of intravenous immunoglobulin for Stevens–Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants
S.J. Romero-Tapia, H.H. Cámara-Combaluzier, M.A. Baeza-Bacab, R. Cerino-Javier, D.P. Bulnes-Mendizabal, C. Virgen-Ortega
Allergol Immunopathol (Madr). 2015;43:227-9
Timing isn’t everything: A case of recurrent angio-oedema
A. Pham, S. Hariri, J. Yusin
Allergol Immunopathol (Madr). 2015;43:230-1
Contact urticaria to Cannabis sativa due to a lipid transfer protein (LTP)
P. Rojas Pérez-Ezquerra, L. Sánchez-Morillas, G. Davila-Ferandez, F.J. Ruiz-Hornillos, I. Carrasco García, M. Herranz Mañas, J.J. Laguna Martínez, B. Bartolomé
Allergol Immunopathol (Madr). 2015;43:231-3
DRESS syndrome induced by meropenem
M. Prados-Castaño, M. Piñero-Saavedra, S. Leguísamo-Milla, M. Ortega-Camarero, A. Vega-Rioja
Allergol Immunopathol (Madr). 2015;43:233-5
In memoriam
Goodbye Tadd
Innes Asher
Allergol Immunopathol (Madr). 2015;43:236
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.